Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- WHG -8.3%, GPC -7.2%, VMC -6.9%, SUN -6.7%, AHH -5.5%, SXC -5%, CNH -4.9%, MDT -4.6%, VMI -4.5%, ALLE -4.2%, GIS -3.4% (guidance), HRI -3.1%, LDOS -1.9%, POR -1.8%, LPX -1.4%, IVA -1.3%, SGI -1.3%, USAC -1.3%
Other news:
- OCUL -30.6% (topline results from the SOL-1 Phase 3 superiority trial of AXPAXLI, its investigational product candidate, for the treatment of wet age-related macular degeneration)
- VMC -7.5% (increases quarterly cash dividend to $0.52/share from $0.49/share)
- WPM -2.3% (production guidance)
- STEX -1.7% (files prospectus supplement relating to 2,443,750 shares; supplement relates to the resale from time to time by the Selling Stockholder)
Analyst comments:
- BBWI -2.4% (downgraded to Neutral from Buy at Citigroup)
- DG -0.6% (downgraded to Sell from Neutral at Rothschild & Co Redburn)